Page last updated: 2024-11-08

aurantiamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

aurantiamide: a Src kinase ligand; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID185904
CHEMBL ID475827
SCHEMBL ID4372161
MeSH IDM0575849

Synonyms (15)

Synonym
n-((1s)-1-(((2s)-1-hydroxy-3-phenyl-propan-2-yl)carbamoyl)-2-phenyl-ethyl)benzamide
58115-31-4
CHEMBL475827
n-[(2s)-1-[[(2s)-1-hydroxy-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]benzamide
SCHEMBL4372161
aurantiamide
AKOS032962235
DTXSID90893261
n-benzoylphenylalanylphenylalaninol
Q63409338
HY-N2909
CS-0023505
MS-26862
E88650
benzenepropanamide, -(benzoylamino)-n-[1-(hydroxymethyl)-2-phenylethyl]-, [s-(r*,r*)]-; (s)--(benzoylamino)-n-[(1s)-1-(hydroxymethyl)-2-phenylethyl]benzenepropanamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID414789Cytotoxicity against human HepG2(2.2.15) cells treated for 9 days measured after 24 hrs of last treatment by neutral red uptake assay2009Bioorganic & medicinal chemistry, Apr-15, Volume: 17, Issue:8
Synthesis and anti-hepatitis B virus activities of Matijing-Su derivatives.
AID414792Antiviral activity against HBV in human HepG2(2.2.15) cells assessed as inhibition of HBsAg production after 9 days by enzyme immunoassay2009Bioorganic & medicinal chemistry, Apr-15, Volume: 17, Issue:8
Synthesis and anti-hepatitis B virus activities of Matijing-Su derivatives.
AID1434705Cytotoxicity against LPS-induced mouse N9 cells assessed as decrease in cell viability at 1 to 100 ug/ml after 24 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Natural potential neuroinflammatory inhibitors from Alhagi sparsifolia Shap.
AID1434704Antineuroinflammatory activity in mouse N9 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Natural potential neuroinflammatory inhibitors from Alhagi sparsifolia Shap.
AID414793Antiviral activity against HBV in human HepG2(2.2.15) cells assessed as inhibition of HBeAg production after 9 days by enzyme immunoassay2009Bioorganic & medicinal chemistry, Apr-15, Volume: 17, Issue:8
Synthesis and anti-hepatitis B virus activities of Matijing-Su derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's4 (50.00)24.3611
2020's3 (37.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.50 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index5.21 (4.65)
Search Engine Demand Index30.68 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]